Beta Bionics Inc.
BBNX | NASDAQ
$16.50
-$0.25 (-1.49%)
Nov 2, 2026, 9:44 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | 100.25M | 65.12M | 12M | 179K |
Cost of Revenue | 44.71M | 29.24M | 5.69M | n/a |
Gross Profit | 55.54M | 35.89M | 6.31M | 179K |
Operating Income | -71.68M | -45.25M | -35.85M | -65.84M |
Interest Income | 10.93M | 3.91M | 1.78M | 196K |
Pretax Income | -73.2M | -54.76M | -44.1M | -64.75M |
Net Income | -73.2M | -54.76M | -44.1M | -64.75M |
Selling & General & Admin | 92.43M | 54.96M | 24.22M | 33.5M |
Research & Development | 34.79M | 26.18M | 17.94M | 31.43M |
Other Expenses | n/a | n/a | n/a | 1.1M |
Operating Expenses | 127.22M | 81.14M | 42.16M | 66.02M |
Interest Expense | n/a | n/a | n/a | 14K |
Selling & Marketing Expenses | 61.4M | 37.09M | 11.99M | 8.83M |
Cost & Expenses | 171.93M | 110.38M | 47.85M | 66.02M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 40.53M | 42.86M | 42.86M | 42.86M |
Shares Outstanding (Diluted) | 40.53M | 42.86M | 42.86M | 42.86M |
EPS (Basic) | -1.81 | -1.28 | -1.03 | -1.51 |
EPS (Diluted) | -1.81 | -1.28 | -1.03 | -1.51 |
EBITDA | -70.32M | -52.47M | -42.01M | -62.66M |
EBIT | -73.2M | -54.76M | -44.1M | -64.74M |
Depreciation & Amortization | 2.88M | 2.28M | 2.09M | 2.09M |
Add to Watchlist
Select watchlists to add or remove BBNX